✦ LIBER ✦

VHL gene mutations in renal cell carcinoma: Role as a biomarker of disease outcome and drug efficacy

✍ Scribed by Cowey, C. Lance (author);Rathmell, W. Kimryn (author)

Book ID: 107546662
Publisher: Current Science Inc.
Year: 2009
Tongue: English
Weight: 446 KB
Volume: 11
Category: Article
ISSN: 1523-3790
DOI: 10.1007/s11912-009-0015-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

VHLgene mutations in renal cell carcinom

VHLgene mutations in renal cell carcinoma: Role as a biomarker of disease outcome and drug efficacy

✍ C. Lance Cowey; W. Kimryn Rathmell 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 446 KB

Mutations of the VHL gene in sporadic re

Mutations of the VHL gene in sporadic renal cell carcinoma: Definition of a risk factor for VHL patients to develop an RCC

✍ C. Gallou; D. Joly; A. Méjean; F. Staroz; N. Martin; G. Tarlet; M.T. Orfanelli; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB 👁 2 views

## Communicated by Albert de la Chapelle To investigate the nature of somatic von Hippel-Lindau (VHL) mutations, we analyzed 173 primary sporadic human renal cell carcinomas for mutations of the VHL tumor suppressor gene, using polymerase chain reaction (PCR) and single-strand conformational polym

Loss of HNF1α function in human renal ce

Loss of HNF1α function in human renal cell carcinoma: Frequent mutations in the VHL gene but not the HNF1α gene

✍ Ira Lemm; Anja Lingott; Elke Pogge v. Strandmann; Christiane Zoidl; Michael P. B 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 1 views

Human renal cell carcinoma (RCC) is a common malignant disease of the kidney characterized by dedifferentiation of renal epithelial cells. Our previous experiments showed that most RCCs have a loss of function of the tissue-specific transcription factor hepatocyte nuclear factor (HNF) 1α. Detailed a